Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clover Health Investments, Corp. - Class A Common stock (NQ:CLOV)

2.875 -0.045 (-1.54%)
Streaming Delayed Price Updated: 1:05 PM EDT, Jun 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Clover Health Investments, Corp. - Class A Common stock

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Clover Stock Looks Attractive as Company Expands Into New Areas
The healthcare sector is expected to continue to grow in the coming years as the population ages, making CLOV stock attractive. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
The 3 Best SPACs to Own in 2022
The mania collapsed, but there are a few old fan favorites still kicking. These are three best SPACs to own after this year's correction. 
Via InvestorPlace
Will Chamath Finally Do A Deal For His IPOF SPAC? (19 Months Later)
Chamath Palihapitiya was known as the SPAC King in 2020, 
Via Talk Markets
Clover Health Investments Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q1, Clover Health Investments's (NASDAQ:CLOV) reported sales totaled $874.38 million. Despite a 59.77% increase in earnings, the company posted a loss of... 
Via Benzinga
Clover Health Stock is Cheap, but Still Doesn’t Offer Good Value
Clover Health is moving higher after posting strong revenue. But the price of CLOV stock still doesn't align with its underlying value. 
Via InvestorPlace
The Bottom Could Be Close for Clover Health Stock
If you're holding CLOV stock, you might not be very happy right now, but now is a good time to consider a position in the insurance company. 
Via InvestorPlace
Has Clover Health Finally Bottomed Out?
Clover is delivering improved operational results. Management's better than expected guidance lends positive outlook to CLOV stock. 
Via InvestorPlace
The 7 Best Meme Stocks to Buy Now
The meme stock craze might never be what it was last year, but these meme stocks to buy that are still worth another look. 
Via InvestorPlace
Clover Health’s Earnings Losses Make It One to Avoid for Now
CLOV stock should not be bought until it has positive earnings. The company has good growth to report but needs earnings to lower the risk. 
Via InvestorPlace
Clover Health Was Up 15% Before Turning Lower: What's Going On?
Clover Health Investments Corp (NASDAQ: CLOV) shares are trading lower Tuesday. The stock initially surged after the company reported better-than-expected top-line results and reaffirmed guidance, but... 
Via Benzinga
PTON Stock Alert: 9 Things to Know as Peloton Plummets 15% After Reporting Earnings
Peloton (PTON) is the top trending stock on Yahoo today as the company's shares fall after releasing its fiscal Q3 2022 earnings report. 
Via InvestorPlace
CLOV Stock Pops 15% as Hard-Hit Clover Health Grows Revenue
The health insurance company's share price is popping on news of better-than-expected earnings and strong forward guidance. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning! We're starting off another busy day of trading with a breakdown of the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
It’s Time for Clover Health to Think Outside the Box
A possible revenue stream for Clover Health is their policyholder’s health data. Could that be a way to get CLOV stock out of its funk? 
Via InvestorPlace
77 Stocks Moving In Tuesday's Mid-Day Session
Gainers 
Via Benzinga
30 Stocks Moving in Tuesday's Pre-Market Session
Gainers Vroom, Inc. (NASDAQ: VRM) shares rose 38% to $1.49 in pre-market trading after the company reported better-than-expected Q1 results. 
Via Benzinga
Don’t Buy CLOV Stock Ahead of Earnings Report
CLOV stock doesn't look good because revenue increases don't trump its greater issues. Don't get in ahead of Q1 earnings. 
Via InvestorPlace
Why Clover Health Stock Is Surging After Hours
Clover Health Investments Corp (NASDAQ: CLOV) shares are trading higher in Monday's after-hours session after the company reported better-than-expected top-line results and reaffirmed guidance. 
Via Benzinga
We Asked, You Answered: What Stock Would You Never Buy Again?
Almost all traders have had that moment: A confident stock pick or strategy that backfires and leaves the investor with less money than they had before and vowing never to trade that stock again. 
Via Benzinga
All Bets Are Off Whether Clover Health Stock Surges or Sinks From Here
It's not for certain CLOV stock spikes after its upcoming earnings report, and a lot needs to happen for it to make a true price recovery. 
Via InvestorPlace
Clover Health’s Technology Is Great But With Dead Money
CLOV Stock has great technology but may lack the financial strength to make it in the Medicare Advantage arena. 
Via InvestorPlace
The Clover Health Debate Will Likely Settle With a Bullish Victory
The Clover Health debate is a fiery one and it won't settle except in hindsight. Meanwhile, the better opportunity in CLOV stock is upside. 
Via InvestorPlace
Do Not Think of Clover Stock as a Bargain Yet
Clover Health certainly has the potential, but it carries more risks. Avoid CLOV stock at the current level. 
Via InvestorPlace
Clover Health Is Risky But Offers a Healthy Upside Ahead
Clover Health's robust fourth quarter and upbeat guidance has improved the risk/reward opportunity of CLOV stock. 
Via InvestorPlace
Clover Health Stock Is No Longer a Meme Stock
A lack of battleground interest and and Clover Health's improving business bode well for long-term CLOV stock investors. 
Via InvestorPlace
Clover Health Stock May Rise As Millions Could Lose Health Coverage
CLOV stock has been under heavy selling pressure, but brighter days should lie ahead as Clover Health offers insure-tech solutions. 
Via InvestorPlace
Clover Stock’s Recovery Could Reverse in the Short-Term
The rebound in growth stocks, not its fundamentals, has been what is fueling the steady rebound in the price of CLOV stock since March. 
Via InvestorPlace
Clover Health Stock’s Outlook Has Improved, but It’s Still a Sell
Clover's profitability is improving but remains dismal, while it seems to lack competitive advantages. As a result, CLOV stock is a sell. 
Via InvestorPlace
Clover Health Is in Need of a Break After Massive Upsurge This Past Month
CLOV stock has seen positive momentum since its earnings release. Due to this, it may become a speculative investment again in the short run. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.